Showing results (41-50 of 653) with videos related to

Sort By:
Pageof 66
Anticancer Research|July 15, 2009
Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancerKoji Oba, Michiya Kobayashi, Takanori Matsui, et al.
Transplant Immunology|December 27, 2016
Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibitionKenta Iwasaki, Yuko Miwa, Kazuharu Uchida, et al.
Hepatobiliary Surgery and Nutrition|May 10, 2014
Management of hepatocellular carcinoma should consider both tumor factors and background liver factorsShuji Nomoto, Mitsuhiro Hishida, Yoshikuni Inokawa, et al.
Australasian Radiology|December 4, 2003
Intractable massive ascites following radical gastrectomy, treatment with local intraperitoneal administration of OK-432 using a unified CT and fluoroscopy systemYoshitaka Inaba, Yasuaki Arai, Kiyoshi Matsueda, et al.
Diseases of the Colon and Rectum|March 29, 2005
Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasisKenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Digestive Surgery|July 23, 2013
Gastric cancer staging with radiologic imaging modalities and UICC staging systemHye Seong Ahn, Se Hyung Kim, Yasuhiro Kodera, et al.
Hepato-Gastroenterology|August 12, 2011
Decreased expression and aberrant hypermethylation of the SFRP genes in human gastric cancerTakashi Kinoshita, Shuji Nomoto, Yasuhiro Kodera, et al.
Cancer Science|May 27, 2010
Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LVYuichi Ito, Hayao Nakanishi, Yasuhiro Kodera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Plasminogen activator inhibitor-1 as a potential marker for the malignancy of esophageal squamous cell carcinomaTakumi Sakakibara, Kenji Hibi, Yasuhiro Kodera, et al.
Anticancer Research|March 2, 2005
Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinomaKenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Pageof 66